Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

US Radiopharmaceutical Market Insights, Forecast to 2027

Published by QYResearch Product code 1004266
Published Content info 107 Pages
Delivery time: 2-3 business days
Price
Back to Top
US Radiopharmaceutical Market Insights, Forecast to 2027
Published: May 7, 2021 Content info: 107 Pages
Description

Market Analysis and Insights: US Radiopharmaceutical Market

The US Radiopharmaceutical market is valued at US$ 2381.19 million in 2020. The market size will reach US$ 3896.82 million by the end of 2027, growing at a CAGR of 7.54% during 2021-2027.

US Radiopharmaceutical Scope and Segment

Radiopharmaceutical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the US Radiopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2016-2027.

Key companies in US

Cardinal Health

GE Healthcare

Jubilant Pharma

Novartis

Curium Pharma

SIEMENS

Lantheus

Bracco Imaging

Bayer

Eli Lilly

Segment by Type

Diagnostic Radiopharmaceutical

Therapeutic Radiopharmaceutical

Segment by Application

Oncology

Cardiology

Other

Table of Contents

TABLE OF CONTENTS

1 STUDY COVERAGE

  • 1.1 Radiopharmaceutical Product Introduction
  • 1.2 Market by Type
    • 1.2.1 US Radiopharmaceutical Market Size Growth Rate by Type
    • 1.2.2 Diagnostic Radiopharmaceutical
    • 1.2.3 Therapeutic Radiopharmaceutical
  • 1.3 Market by Application
    • 1.3.1 US Radiopharmaceutical Market Size Growth Rate by Application
    • 1.3.2 Oncology
    • 1.3.3 Cardiology
  • 1.4 Executive Summary
    • 1.4.1 US Radiopharmaceutical Sales Estimates and Forecasts 2016-2027
    • 1.4.2 US Radiopharmaceutical Revenue Estimates and Forecasts 2016-2027
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 COMPETITION BY MANUFACTURER

  • 2.1 US Radiopharmaceutical Sales by Manufacturer
    • 2.1.1 US Radiopharmaceutical Sales by Manufacturer (2019-2021)
    • 2.1.2 US Radiopharmaceutical Sales Market Share by Manufacturer (2019-2021)
    • 2.1.3 Top 3 and Top 5 Companies in US by Radiopharmaceutical Sales in 2020
  • 2.2 US Radiopharmaceutical Revenue by Manufacturer
    • 2.2.1 US Radiopharmaceutical Revenue by Manufacturer (2019-2021)
    • 2.2.2 US Radiopharmaceutical Revenue Market Share by Manufacturer (2019-2021)
    • 2.2.3 Top 3 and Top 5 Companies in US by Radiopharmaceutical Revenue in 2020
  • 2.3 US Radiopharmaceutical Sales Price by Manufacturer
  • 2.4 Analysis of Competitive Landscape
    • 2.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.4.2 US Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3)
    • 2.4.3 US Radiopharmaceutical Manufacturers Geographical Distribution
  • 2.5 Mergers & Acquisitions, Expansion Plans

3 MARKET SIZE BY TYPE

  • 3.1 US Radiopharmaceutical Sales by Type
    • 3.1.1 US Radiopharmaceutical Historical Sales by Type (2016-2021)
    • 3.1.2 US Radiopharmaceutical Forecasted Sales by Type (2022-2027)
    • 3.1.3 US Radiopharmaceutical Sales Market Share by Type (2016-2027)
  • 3.2 US Radiopharmaceutical Revenue by Type
    • 3.2.1 US Radiopharmaceutical Historical Revenue by Type (2016-2021)
    • 3.2.2 US Radiopharmaceutical Forecasted Revenue by Type (2022-2027)
    • 3.2.3 US Radiopharmaceutical Revenue Market Share by Type (2016-2027)
  • 3.3 US Radiopharmaceutical Price by Type
    • 3.3.1 US Radiopharmaceutical Price by Type (2016-2021)
    • 3.3.2 US Radiopharmaceutical Price Forecast by Type (2022-2027)

4 MARKET SIZE BY APPLICATION

  • 4.1 US Radiopharmaceutical Sales by Application
    • 4.1.1 US Radiopharmaceutical Historical Sales by Application (2016-2021)
    • 4.1.2 US Radiopharmaceutical Forecasted Sales by Application (2022-2027)
    • 4.1.3 US Radiopharmaceutical Sales Market Share by Application (2016-2027)
  • 4.2 US Radiopharmaceutical Revenue by Application
    • 4.2.1 US Radiopharmaceutical Historical Revenue by Application (2016-2021)
    • 4.2.2 US Radiopharmaceutical Forecasted Revenue by Application (2022-2027)
    • 4.2.3 US Radiopharmaceutical Revenue Market Share by Application (2016-2027)
  • 4.3 US Radiopharmaceutical Price by Application
    • 4.3.1 US Radiopharmaceutical Price by Application (2016-2021)
    • 4.3.2 US Radiopharmaceutical Price Forecast by Application (2022-2027)

5 CORPORATE PROFILE

  • 5.1 Cardinal Health
    • 5.1.1 Cardinal Health Corporation Information
    • 5.1.2 Cardinal Health Overview
    • 5.1.3 Cardinal Health in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.1.4 Cardinal Health Radiopharmaceutical Product Description
    • 5.1.5 Cardinal Health Recent Developments
  • 5.2 GE Healthcare
    • 5.2.1 GE Healthcare Corporation Information
    • 5.2.2 GE Healthcare Overview
    • 5.2.3 GE Healthcare in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.2.4 GE Healthcare Radiopharmaceutical Product Description
    • 5.2.5 GE Healthcare Recent Developments
  • 5.3 Jubilant Pharma
    • 5.3.1 Jubilant Pharma Corporation Information
    • 5.3.2 Jubilant Pharma Overview
    • 5.3.3 Jubilant Pharma in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.3.4 Jubilant Pharma Radiopharmaceutical Product Description
    • 5.3.5 Jubilant Pharma Recent Developments
  • 5.4 Novartis
    • 5.4.1 Novartis Corporation Information
    • 5.4.2 Novartis Overview
    • 5.4.3 Novartis in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.4.4 Novartis Radiopharmaceutical Product Description
    • 5.4.5 Novartis Recent Developments
  • 5.5 Curium Pharma
    • 5.5.1 Curium Pharma Corporation Information
    • 5.5.2 Curium Pharma Overview
    • 5.5.3 Curium Pharma in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.5.4 Curium Pharma Radiopharmaceutical Product Description
    • 5.5.5 Curium Pharma Recent Developments
  • 5.6 SIEMENS
    • 5.6.1 SIEMENS Corporation Information
    • 5.6.2 SIEMENS Overview
    • 5.6.3 SIEMENS in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.6.4 SIEMENS Radiopharmaceutical Product Description
  • 5.7 Lantheus
    • 5.7.1 Lantheus Corporation Information
    • 5.7.2 Lantheus Overview
    • 5.7.3 Lantheus in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.7.4 Lantheus Radiopharmaceutical Product Description
    • 5.7.5 Lantheus Recent Developments
  • 5.8 Bracco Imaging
    • 5.8.1 Bracco Imaging Corporation Information
    • 5.8.2 Bracco Imaging Overview
    • 5.8.3 Bracco Imaging in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.8.4 Bracco Imaging Radiopharmaceutical Product Description
    • 5.8.5 Bracco Imaging Recent Developments
  • 5.9 Bayer
    • 5.9.1 Bayer Corporation Information
    • 5.9.2 Bayer Overview
    • 5.9.3 Bayer in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.9.4 Bayer Radiopharmaceutical Product Description
    • 5.9.5 Bayer Recent Developments
  • 5.10 Eli Lilly
    • 5.10.1 Eli Lilly Corporation Information
    • 5.10.2 Eli Lilly Overview
    • 5.10.3 Eli Lilly in US: Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2021)
    • 5.10.4 Eli Lilly Radiopharmaceutical Product Description
    • 5.10.5 Eli Lilly Recent Developments

6 VALUE CHAIN ANALYSIS

  • 6.1 Radiopharmaceutical Value Chain Analysis
  • 6.2 Radiopharmaceutical Key Raw Materials
    • 6.2.1 Key Raw Materials
    • 6.2.2 Raw Materials Key Suppliers
  • 6.3 Radiopharmaceutical Production Mode & Process
  • 6.4 Radiopharmaceutical Customers

7 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS

  • 7.1 Radiopharmaceutical Industry Trends
  • 7.2 Radiopharmaceutical Market Drivers
  • 7.3 Radiopharmaceutical Market Challenges

8 KEY FINDINGS IN THE US RADIOPHARMACEUTICAL STUDY

9 APPENDIX

  • 9.1 Research Methodology
    • 9.1.1 Methodology/Research Approach
    • 9.1.2 Data Source
  • 9.2 Author Details
  • 9.3 Disclaimer 94

List of Tables and Figures

  • Table 1. Specifications of Technetium-99m
  • Table 2. Classification of Radiopharmaceuticals
  • Table 3. US Radiopharmaceutical Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
  • Table 4. Major Manufacturers of Therapeutic Radiopharmaceutical
  • Table 5. US Radiopharmaceutical Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
  • Table 6. US Radiopharmaceutical Sales by Manufacturer (2019-2021) & (K Doses)
  • Table 7. US Radiopharmaceutical Sales Share by Manufacturer (2019-2021)
  • Table 8. US Radiopharmaceutical Revenue by Manufacturer (2019-2021) & (US$ Million)
  • Table 9. US Radiopharmaceutical Revenue Share by Manufacturer (2019-2021)
  • Table 10. US Radiopharmaceutical Price by Manufacturer 2019-2021 (US$/Doses)
  • Table 11. US Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 12. US Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2020)
  • Table 13. Radiopharmaceutical Manufacturing Base Distribution and Headquarters
  • Table 14. Manufacturers Radiopharmaceutical Product Offered
  • Table 15. Founded Date of Manufacturers
  • Table 16. Mergers & Acquisitions, Expansion Plans
  • Table 17. US Radiopharmaceutical Sales by Type (2016-2021) & (K Doses)
  • Table 18. US Radiopharmaceutical Sales by Type (2022-2027) & (K Doses)
  • Table 19. US Radiopharmaceutical Sales Share by Type (2016-2021)
  • Table 20. US Radiopharmaceutical Sales Share by Type (2022-2027)
  • Table 21. US Radiopharmaceutical Revenue by Type (2016-2021) & (US$ Million)
  • Table 22. US Radiopharmaceutical Revenue by Type (2022-2027) & (US$ Million)
  • Table 23. US Radiopharmaceutical Revenue Share by Type (2016-2021)
  • Table 24. US Radiopharmaceutical Revenue Share by Type (2022-2027)
  • Table 25. US Radiopharmaceutical Price by Type (2016-2021) & (US$/Doses)
  • Table 26. US Radiopharmaceutical Price Forecast by Type (2022-2027) & (US$/Doses)
  • Table 27. US Radiopharmaceutical Sales by Application (2016-2021) & (K Doses)
  • Table 28. US Radiopharmaceutical Sales by Application (2022-2027) & (K Doses)
  • Table 29. US Radiopharmaceutical Sales Share by Application (2016-2021)
  • Table 30. US Radiopharmaceutical Sales Share by Application (2022-2027)
  • Table 31. US Radiopharmaceutical Revenue by Application (2016-2021) & (US$ Million)
  • Table 32. US Radiopharmaceutical Revenue by Application (2022-2027) & (US$ Million)
  • Table 33. US Radiopharmaceutical Revenue Share by Application (2016-2021)
  • Table 34. US Radiopharmaceutical Revenue Share by Application (2022-2027)
  • Table 35. Radiopharmaceutical Price by Application (2016-2021) & (US$/Doses)
  • Table 36. US Radiopharmaceutical Price Forecast by Application (2022-2027) & (US$/Doses)
  • Table 37. Cardinal Health Corporation Information
  • Table 38. Cardinal Health Description and Major Businesses
  • Table 39. Cardinal Health in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 40. Cardinal Health Radiopharmaceutical Product
  • Table 41. Cardinal Health Recent Developments
  • Table 42. GE Healthcare Corporation Information
  • Table 43. GE Healthcare Description and Major Businesses
  • Table 44. GE Healthcare in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 45. GE Healthcare Recent Developments
  • Table 46. Jubilant Pharma Corporation Information
  • Table 47. Jubilant Pharma Description and Major Businesses
  • Table 48. Jubilant Pharma in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 49. Jubilant Pharma Radiopharmaceutical Product
  • Table 50. Jubilant Pharma Recent Developments
  • Table 51. Novartis Corporation Information
  • Table 52. Novartis Description and Major Businesses
  • Table 53. Novartis in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 54. Novartis Radiopharmaceutical Product
  • Table 55. Novartis Recent Developments
  • Table 56. Curium Pharma Corporation Information
  • Table 57. Curium Pharma Description and Major Businesses
  • Table 58. Curium Pharma in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 59. Curium Pharma Radiopharmaceutical Product
  • Table 60. Curium Pharma Recent Developments
  • Table 61. SIEMENS Corporation Information
  • Table 62. SIEMENS Description and Major Businesses
  • Table 63. SIEMENS in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 64. Lantheus Corporation Information
  • Table 65. Lantheus Description and Major Businesses
  • Table 66. Lantheus in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 67. Lantheus Radiopharmaceutical Product
  • Table 68. Lantheus Recent Developments
  • Table 69. Bracco Imaging Corporation Information
  • Table 70. Bracco Imaging Description and Major Businesses
  • Table 71. Bracco Imaging in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 72. Bracco Imaging Radiopharmaceutical Product
  • Table 73. Bracco Imaging Recent Developments
  • Table 74. Bayer Corporation Information
  • Table 75. Bayer Description and Major Businesses
  • Table 76. Bayer in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 77. Bayer Radiopharmaceutical Product
  • Table 78. Bayer Recent Developments
  • Table 79. Eli Lilly Corporation Information
  • Table 80. Eli Lilly Description and Major Businesses
  • Table 81. Eli Lilly in US: Radiopharmaceutical Sales (K Doses), Revenue (US$ Million), Price (US$/Doses) and Gross Margin (2019-2021)
  • Table 82. Eli Lilly Recent Developments
  • Table 83. Key Raw Materials Lists
  • Table 84. Raw Materials Key Suppliers Lists
  • Table 85. Radiopharmaceutical Customers List
  • Table 86. Radiopharmaceutical Market Trends
  • Table 87. Radiopharmaceutical Market Drivers
  • Table 88. Radiopharmaceutical Market Challenges
  • Table 89. Research Programs/Design for This Report
  • Table 90. Key Data Information from Secondary Sources
  • Table 91. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Radiopharmaceutical Product Picture
  • Figure 2. US Radiopharmaceutical Market Share by Type in 2020
  • Figure 3. US Radiopharmaceutical Market Share by Type in 2027
  • Figure 4. Diagnostic Radiopharmaceutical Product Picture
  • Figure 5. Major Manufacturers of Diagnostic Radiopharmaceutical
  • Figure 6. Therapeutic Radiopharmaceutical Product Picture
  • Figure 7. US Radiopharmaceutical Market Share by Application in 2020
  • Figure 8. US Radiopharmaceutical Market Share by Application in 2027
  • Figure 9. Oncology
  • Figure 10. Cardiology
  • Figure 11. US Radiopharmaceutical Sales 2016-2027 (K Doses)
  • Figure 12. US Radiopharmaceutical Revenue, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 13. US Radiopharmaceutical Revenue 2016-2027 (US$ Million)
  • Figure 14. Radiopharmaceutical Report Years Considered
  • Figure 15. The Top 3 Players Market Share by Radiopharmaceutical Sales in US: 2020
  • Figure 16. The Top 5 Players Market Share by Radiopharmaceutical Sales in US: 2020
  • Figure 17. The Top 3 Players Market Share in US by Radiopharmaceutical Revenue: 2020
  • Figure 18. The Top 5 Players Market Share in US by Radiopharmaceutical Revenue: 2020
  • Figure 19. US Radiopharmaceutical Sales Market Share by Type (2016-2027)
  • Figure 20. US Radiopharmaceutical Revenue Market Share by Type (2016-2027)
  • Figure 21. US Radiopharmaceutical Sales Market Share by Application (2016-2027)
  • Figure 22. US Radiopharmaceutical Revenue Market Share by Application (2016-2027)
  • Figure 23. GE Healthcare Radiopharmaceutical Product
  • Figure 24. SIEMENS Radiopharmaceutical Product
  • Figure 25. Eli Lilly Radiopharmaceutical Product
  • Figure 26. Radiopharmaceutical Value Chain
  • Figure 27. Radiopharmaceutical Production Process
  • Figure 28. Bottom-up and Top-down Approaches for This Report
  • Figure 29. Data Triangulation
  • Figure 30. Key Executives Interviewed
Back to Top